Mast cells in chronic inflammation, pelvic pain and depression in women

Gynecological Endocrinology

Volumn 30, Issue 7, 2014, Pages 472-477

  Graziottin, Alessandra ^a   Skaper, Stephen D ^b   Fusco, Mariella ^c  

^a Center of Gynecology and Medical Sexology   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Scientific Information and Documentation Center Epitech Group Srl   (Italy)

Author keywords

Anxiety; Chronic pelvic pain; Depression; Mast cells; Persistent inflammation

Indexed keywords

ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; CHRONIC INFLAMMATION; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MAST CELL; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; TISSUE REACTION; METABOLISM; PATHOLOGY; PELVIC PAIN; PSYCHOLOGY;

AUTACOID;

COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS; PELVIC PAIN;

EID: 84903142294     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.911280     Document Type: Article

References (72)

1. Poleshuck EL, Bair MJ, Kroenke K, et al. Pain and depression in gynecology patients. Psychosomatics 2009;50: 270-6.
2. Boettger MK, Grossmann D, Bär KJ. Thresholds and perception of cold pain, heat pain, and the thermal grill illusion in patients with major depressive disorder. Psychosom Med 2013;75: 281-7.
3. Poleshuck EL, Gamble SA, Cort N, et al. Interpersonal psychotherapy for co-occurring depression and chronic pain. Prof Psychol Res Pr 2010;41: 312-18.
4. Bair MJ, Robinson RL, Eckert GJ, et al. Impact of pain on depression treatment response in primary care. Psychosom Med 2004;66: 17-22.
5. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9: 46-56.
6. Kinet JP. The essential role of mast cells in orchestrating inflammation. Immunol Rev 2007;217: 5-7.
7. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010;10: 440-52.
8. Nelissen S, Lemmens E, Geurts N, et al. The role of mast cells in neuroinflammation. Acta Neuropathol 2013;125: 637-50.
9. Beghdadi W, Madjene LC, Benhamou M, et al. Mast cells as cellular sensors in inflammation and immunity. Front Immunol 2011;2:37.
10. Bulanova E, Bulfone-Paus S. P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 2010;6: 3-17.
11. Levi-Montalcini R, Skaper SD, Dal Toso R, et al. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996;19: 514-20.
12. Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 2007;217: 19-37.
13. Wasse H, Naqvi N, Husain A. Impact of mast cell chymase on renal disease progression. Curr Hypertens Rev 2012;8: 15-23.
14. Shaik-Dasthagirisaheb YB, Varvara G, Murmura G, et al. Vascular endothelial growth factor (VEGF), mast cells and inflammation. Int J Immunopathol Pharmacol 2013;26: 327-35.
15. Osuga Y, Koga K, Tsutsumi O, et al. Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. Am J Reprod Immunol. 2000;44: 231-5.
16. Konno R, Yamada-Okabe H, Fujiwara H, et al. Role of immunoreactions and mast cells in pathogenesis of human endometriosis- morphologic study and gene expression analysis. Hum Cell 2003;16: 141-9.
17. Fujiwara H, Konno R, Netsu S, et al. Localization of mast cells in endometrial cysts. Am J Reprod Immunol 2004; 51: 341-4.
18. Bohm-Starke N, Hilliges M, Brodda-Jansen G, et al. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 2001;94: 177-83.
19. Bornstein J, Cohen Y, Zarfati D, et al. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol 2008; 27: 136-41.
20. Kastrup J, Hald T, Larsen S, Nielsen VG. Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol 1983;55: 495-500.
21. Aldenborg F, Fall M, Enerback L. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology 1986;58: 411-6.
22. Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol 1995;75: 154-61.
23. Yamada T, Murayama T, Mita H, Akiyama K. Subtypes of bladder mast cells in interstitial cystitis. Int J Urol 2000;7: 292-7.
24. Peeker R, Enerbäck L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol 2000; 163: 1009-15.
25. Lv J, Huang Y, Zhu S, et al. MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/ bladder pain syndrome in rat models. Mediators Inflamm 2012; 2012:358184.
26. el-Mansoury M, Boucher W, Sant GR, Theoharides TC. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 1994;152: 350-3.
27. Boucher W, el-Mansoury M, Pang X, et al. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 1995; 76: 94-100.
28. Lotz M, Villiger P, Hugli T, et al. Interleukin-6 and interstitial cystitis. J Urol 1994;152: 869-73.
29. Liu HT, Tyagi P, Chancellor MB, Kuo HC. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 2009; 104: 1476-81.
30. Weston AP, Biddle WL, Bhatia PS, Miner Jr PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5.
31. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126: 693-702.
32. Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008;23: 1689-94.
33. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104: 392-400.
34. Willot S, Gauthier C, Patey N, Faure C. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea- predominant irritable bowel syndrome. Neurogastroenterol Motil 2012;24: 734-9.
35. Anand P, Singh B, Jaggi AS, Singh N. Mast cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol 2012;385: 657-70.
36. Héron A, Dubayle D. A focus on mast cells and pain. J Neuroimmunol 2013;264: 1-7.
37. Levy D. Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 2009;13: 237-40.
38. Michaloudi H, Batzios C, Chiotelli M, et al. Mast cells populations fluctuate along the spinal dura mater of the developing rat. Brain Res. 2008;1226: 8-17.
39. Genovese T, Esposito E, Mazzon E, et al. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 2008;326: 12-23.
40. Esposito E, Paterniti I, Mazzon E, et al. Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun 2011;25: 1099-112.
41. Xanthos DN, Gaderer S, Drdla R, et al. Central nervous system mast cells in peripheral inflammatory nociception. Mol Pain 2011;7:42.
42. Taiwo OB, Kovács KJ, Sun Y, Larson AA. Unilateral spinal nerve ligation leads to an asymmetrical distribution of mast cells in the thalamus of female but not male mice. Pain 2005;114: 131-40.
43. Zuo Y, Perkins NM, Tracey DJ, Geczy CL. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 2003;105: 467-79.
44. Bettoni I, Comelli F, Colombo A, et al. Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide. CNS Neurol Disord Drug Targets 2013;12: 34-44.
45. Hayashi R, Xiao W, Kawamoto M, et al. Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci 2008;106: 559-65.
46. Anaf V, Chapron C, El Nakadi I, et al. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. Fertil Steril 2006;86: 1336-43.
47. Zhang X, Lu B, Huang X, et al. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril 2009;92: 1799-801.
48. Rocha MG, e Silva JC, Ribeiro da Silva A, et al. TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain. Reprod Sci 2011;18: 511-5.
49. Buhner S, Li Q, Vignali S, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009;137: 1425-34.
50. Akbar A, Yiangou Y, Facer P, et al. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010;59: 767-74.
51. Ustinova EE, Gutkin DW, Pezzone MA. Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides. Am J Physiol Renal Physiol 2007;292:F123-30.
52. Fitzgerald JJ, Ustinova E, Koronowski KB, et al. Evidence for the role of mast cells in colon-bladder cross organ sensitization. Auton Neurosci 2013;173: 6-13.
53. Yuan H, Zhu X, Zhou S, et al. Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res 2010;88: 1348-54.
54. Skaper SD, Facci L, Fusco M, et al. Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology. 2014;22: 79-94.
55. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65: 732-41.
56. Nelissen S, Lemmens E, Geurts N, et al. The role of mast cells in neuroinflammation. Acta Neuropathol 2013;125: 637-50.
57. Theoharides TC, Spanos C, Pang X, et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormonemediated effect. Endocrinology 1995;136: 5745-50.
58. Cao J, Papadopoulou N, Kempuraj D, et al. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005;174: 7665-75.
59. Esposito P, Gheorghe D, Kandere K, et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res 2001;888: 117-27.
60. Ahmad A, Genovese T, Impellizzeri D, et al. Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats. Brain Res 2012; 1477: 45-58.
61. Lehrer PM, Isenberg S, Hochron SM. Asthma and emotion: a review. J Asthma 1993;30: 5-21.
62. Moura DS, Sultan S, Georgin-Lavialle S, et al. Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS One 2012;7:e39468.
63. Nautiyal KM, Ribeiro AC, Pfaff DW, Silver R. Brain mast cells link the immune system to anxiety-like behavior. Proc Natl Acad Sci USA. 2008;105: 18053-7.
64. Nautiyal KM, Dailey CA, Jahn JL, et al. Serotonin of mast cell origin contributes to hippocampal function. Eur J Neurosci 2012;36: 2347-59.
65. Dunn AJ. Cytokine activation of the HPA axis. Ann N Y Acad Sci 2000;917: 608-17.
66. Indraccolo U, Barbieri F. Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations. Eur J Obstet Gynecol Reprod Biol 2010; 150: 76-9.
67. Calabrò RS, Gervasi G, Marino S, et al. Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide. Pain Med 2010;11: 781-4.
68. Cobellis L, Castaldi MA, Giordano V, et al. Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study. Eur J Obstet Gynecol Reprod Biol 2011;158: 82-6.
69. Giugliano E, Cagnazzo E, Soave I, et al. The adjuvant use of N-Palmitoylethanolamine and transpolydatin in the treatment of the endometriotic pain. Eur J Obstet Gynecol Reprod Biol 2013;168: 209-13.
70. Manchanda RK, Jaggi AS, Singh N. Ameliorative potential of sodium cromoglycate and diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats. Pharmacol Rep 2011; 63: 54-63.
71. Yu HL, Deng XQ, Li YJ, et al. N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice. Pharmacol Rep 2011;63: 834-9.
72. Crupi R, Paterniti I, Ahmad A, et al. Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression. CNS Neurol Disorders - Drug Targets 2013;12:989-1001.